Koo Jakap 4
4 · Apimeds Pharmaceuticals US, Inc. · Filed May 20, 2025
Insider Transaction Report
Form 4
Koo Jakap
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-16+5,780→ 5,780 totalExercise: $1.73Exp: 2035-05-16→ Common Stock, par value $0.01 per share (5,780 underlying)
Footnotes (1)
- [F1]The option will vest in full and become exercisable on 05/16/2026.